Neurofibromatosis 1

被引:110
作者
Ferner, Rosalie E. [1 ]
机构
[1] Guys & St Thomas Hosp, Dept Neurol, London SE1 9RT, England
关键词
neurofibromin; neurofibroma; plexiform neurofibroma; glioma; malignant peripheral nerve sheath tumour;
D O I
10.1038/sj.ejhg.5201676
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurofibromatosis 1 predisposes affected individuals to the development of benign and malignant tumours that are frequently disfiguring and difficult to manage. However, advances in molecular biology and the development of mouse models have facilitated our understanding of disease pathogenesis. Positron emission tomography has demonstrated that sophisticated imaging techniques have a role in diagnosing complex problems like malignant peripheral nerve sheath tumours, while the prospect of targeted therapies for Nf1 complications is tantalisingly close.
引用
收藏
页码:131 / 138
页数:8
相关论文
共 68 条
[1]   Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2 [J].
Abaza, MM ;
Makariou, E ;
Armstrong, M ;
Lalwani, AK .
LARYNGOSCOPE, 1996, 106 (06) :694-699
[2]   Natural history of neurofibromatosis 1-associated optic nerve glioma in mice [J].
Bajenaru, ML ;
Garbow, JR ;
Perry, A ;
Hernandez, MR ;
Gutmann, DH .
ANNALS OF NEUROLOGY, 2005, 57 (01) :119-127
[3]  
BOGNANNO JR, 1988, AM J ROENTGENOL, V151, P381
[4]   Mouse models of tumor development in neurofibromatosis type 1 [J].
Cichowski, K ;
Shih, TS ;
Schmitt, E ;
Santiago, S ;
Reilly, K ;
McLaughlin, ME ;
Bronson, RT ;
Jacks, T .
SCIENCE, 1999, 286 (5447) :2172-2176
[5]   Mouse models of neurofibromatosis type I: bridging the GAP [J].
Costa, RM ;
Silva, AJ .
TRENDS IN MOLECULAR MEDICINE, 2003, 9 (01) :19-23
[6]   Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 [J].
Costa, RM ;
Federov, NB ;
Kogan, JH ;
Murphy, GG ;
Stern, J ;
Ohno, M ;
Kucherlapati, R ;
Jacks, T ;
Silva, AJ .
NATURE, 2002, 415 (6871) :526-530
[7]   OSSEOUS MANIFESTATIONS OF NEUROFIBROMATOSIS IN CHILDHOOD [J].
CRAWFORD, AH ;
BAGAMERY, N .
JOURNAL OF PEDIATRIC ORTHOPAEDICS, 1986, 6 (01) :72-88
[8]   Neurological complications of neurofibromatosis type 1 in adulthood [J].
Créange, A ;
Zeller, J ;
Rostaing-Rigattieri, S ;
Brugières, P ;
Degos, JD ;
Revuz, J ;
Wolkenstein, P .
BRAIN, 1999, 122 :473-481
[9]   Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors [J].
Dasgupta, B ;
Yi, YJ ;
Chen, DY ;
Weber, JD ;
Gutmann, DH .
CANCER RESEARCH, 2005, 65 (07) :2755-2760
[10]   Elevated risk for MPNST in NF1 microdeletion patients [J].
De Raedt, T ;
Brems, H ;
Wolkenstein, P ;
Vidaud, D ;
Pilotti, S ;
Perrone, F ;
Mautner, V ;
Frahm, S ;
Sciot, R ;
Legius, E .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1288-1292